A study led by UTSW researchers found that patients with multiple sclerosis (MS) taking generic versions of three commonly prescribed oral therapies had greater variability in blood proteins associated with MS disease activity than patients taking brand-name versions of the drugs.
❓ Unknown
Study Reveals Variability in MS Drug Efficacy Between Generic and Brand-Name Versions
Just now
October 2, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study by UTSW researchers indicates that multiple sclerosis patients using generic drugs experience more variability in disease-related blood proteins compared to those using brand-name drugs. This research highlights potential concerns regarding the efficacy of generic medications. For Iran, this could impact healthcare policies and drug approvals.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Three Executed in Isfahan: A Woman for Murder and Two Men for Drug Offenses
7 min ago •
Impact of US Pharmacy Closures on Racial Minority Communities
7 min ago •
Research on Plant Cultivation Essential for Future Lunar Bases
8 min ago •
U.K. National Year of Reading Promotes Multilingual Literacy
13 min ago •